JiangXi Guo Yao Factory Passes FDA Inspection

ChemWerth, a supplier of active pharmaceutical ingredients to generic drug manufacturers, is pleased to announce that its partner, JiangXi Guo Yao (Guo Yao) pharmaceutical facility has passed an FDA
overseas inspection.

Guo Yao’s main products exported to the US include Lincomycin HCl and Oxytetracycline HCl. ChemWerth and Guo Yao supply Lincomycin HCl worldwide.

ChemWerth and Guo Yao have collaborated since 1987. Guo Yao was one of the first Chinese factories to supply FDA approved Active Pharmaceutical Ingredients (APIs) to the United States. Guo Yao continues to be a primary supplier of high quality APIs to the Chinese and US markets. ChemWerth also reported that the FDA inspection of Guo Yao cited two minor 483 deficiencies, both of which are being promptly addressed at the facility.

According to Mr. Peter Werth, ChemWerth CEO, “We are very pleased that another one of our partner factories has been successful in passing an FDA inspection. Our regulatory expertise in helping manufacturers like Guo Yao get approved is a real value-added benefit for our customers. We’re proud to have Guo Yao as a manufacturing partner for over 22 years.”